Module

HIV Journal Options-Volume 3, Issue 2

Source: Journal Options

HIV Journal Options-Volume 3, Issue 2


Program Directors: Joseph J. Eron, Jr., MD, William G. Powderly, MD, Andrew R. Zolopa, MD

Faculty:

  • John D. Baxter, MD
  • Bonaventura Clotet, MD, PhD
  • David A. Cooper, MD, DSc
  • Bruce Dezube, MD
  • Trevor Hawkins, MD
  • Liron Pantanowitz, MD
  • José R. Santos Fernández, MD

CME CREDIT INFORMATION

Release Date: 02/28/07

Expiration Date: 02/27/08


Physicians: maximum of 1.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe how patients enrolled in the SMART study responded to antiretroviral treatment interruption compared with patients continuously treated with HAART
  • Recount data from studies that evaluated the integrase inhibitor, MK-0518, in the management of treatment-naive, HIV-infected patients
  • Summarize data evaluating levels of viremia in patients taking lopinavir/ritonavir maintenance therapy compared with those taking lopinavir/ritonavir with 2 NRTIs

Topics covered include:

  • SMART: Risk of Treatment Interruption
  • Use of Ezetimibe for HIV Dyslipidemia
  • Interpreting Early Results on MK-0518
  • Lopinavir/Ritonavir Maintenance Monotherapy
  • AIDS Lymphoma in the HAART Era
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.